HIV encephalitis (HIVE) is characterized by neurodegeneration mediated by toxins derived from infected and activated brain macrophages. Since the peripheral benzodiazepine receptor (PBR) is
Introduction HIV-associated neurological abnormalities are seen in approximately 25% of terminally ill AIDS patients (Cinque et al., 1997 , Dore et al., 1999 . Deficits observed in these individuals range from minor cognitive impairment, motor and psychiatric dysfunctions to frank dementia thought to result from neuronal damage (Nath and Sacktor, 2006) . Neuronal and synaptic injury is attributed to viral proteins and toxic products derived from HIVinfected and activated infiltrating macrophages (Ellis et al., 2007) . These infected and activated macrophages manifest in the brain as microglial nodules, multinucleated giant cells and perivascular macrophage infiltrates, histopathologically referred to as HIVE. SIV infection in macaques has been used to model HIVE with a variable percentage of macaques developing SIVE (Lackner et al., 1991) . Since activated and infected macrophages in the brain are central to the pathology of lentiviral encephalitis, our goal is to image these cells in vivo using PET to enable the detection and progression of lentiviral encephalitis in the macaque model and eventually in human subjects.
Brain macrophages can be imaged in vivo using PET by taking advantage of increased expression of the peripheral benzodiazepine receptor (PBR) (Banati, 2002) . Unlike the central benzodiazepine receptor, PBR is expressed at relatively low levels in the normal brain on resting brain macrophages and astrocytes (Cagnin et al., 2002) . PK11195, the prototype PBR ligand, has been shown to cross the blood brain barrier and achieve specific binding to brain macrophages in both animal models and human subjects with neuroinflammation (Banati, 2002) .
We and others have shown that activated brain macrophages can be labeled with [ 3 H](R)-PK11195 in SIVE (Mankowski et al., 2003; Venneti et al., 2004) and that [ 11 C](R)-PK11195 can be used to image activated brain macrophages in vivo using PET in macaques that develop encephalitis (Venneti et al., 2004) . However, translation of these studies to human subjects has been less promising. [
11 C](R)-PK11195 PET retention in the brain did not differ between HIVinfected patients on retroviral drugs with and without neurological deficits (Hammoud et al., 2005; Wiley et al., 2006) . These findings may be in part due to decreased brain inflammation seen in neurologically impaired HIV-infected subjects on antiretroviral therapy (ART) without frank dementia (Gray and Keohane, 2003; Gray et al., 2003) . It is also possible that 
